HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Characterization of the novel SARS-CoV-2 Omicron (B.1.1.529) variant of concern and its global perspective.

Abstract
As the latest identified novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant of concern (VOC), the influence of Omicron on our globe grows promptly. Compared with the last VOC (Delta variant), more mutations were identified, which may address the characteristics of Omicron. Considering these crucial mutations and their implications including an increase in transmissibility, COVID-19 severity, and reduction of efficacy of currently available diagnostics, vaccines, and therapeutics, Omicron has been classified as one of the VOC. Notably, 15 of these mutations reside in the receptor-binding domain of spike glycoprotein, which may alter transmissibility, infectivity, neutralizing antibody escape, and vaccine breakthrough cases of COVID-19. Therefore, our present study characterizes the mutational hotspots of the Omicron variant in comparison with the Delta variant of SARS-CoV-2. Furthermore, detailed information was analyzed to characterize the global perspective of Omicron, including transmission dynamic, effect on testing, and immunity, which shall promote the progress of the clinical application and basic research. Collectively, our data suggest that due to continuous variation in the spike glycoprotein sequences, the use of coronavirus-specific attachment inhibitors may not be the current choice of therapy for emerging SARS-CoV-2 VOCs. Hence, we need to proceed with a sense of urgency in this matter.
AuthorsShailendra K Saxena, Swatantra Kumar, Saniya Ansari, Janusz T Paweska, Vimal K Maurya, Anil K Tripathi, Ahmed S Abdel-Moneim
JournalJournal of medical virology (J Med Virol) Vol. 94 Issue 4 Pg. 1738-1744 (Apr 2022) ISSN: 1096-9071 [Electronic] United States
PMID34905235 (Publication Type: Journal Article)
Copyright© 2022 Wiley Periodicals LLC.
Chemical References
  • Spike Glycoprotein, Coronavirus
  • spike protein, SARS-CoV-2
Topics
  • COVID-19 (diagnosis, epidemiology, prevention & control, transmission)
  • COVID-19 Testing
  • Humans
  • Immune Evasion (genetics)
  • Mutation
  • Phylogeny
  • Prevalence
  • Protein Binding (genetics)
  • SARS-CoV-2 (genetics, immunology, isolation & purification, metabolism)
  • Spike Glycoprotein, Coronavirus (genetics, immunology, metabolism)
  • Vaccination
  • Virus Attachment

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: